The administration of a bolus dose of intravenous medication is the administration of the prepared medication directly into the bung of a cannula placed into the vein of the person. Alternatively, there may be an infusion of IV fluid in progress, in which case the medication will be administered via an injection port on the IV line. Show
For this route of medication administration the nurse is present throughout the procedure. While administration may take less time than other intravenous administration strategies, the nursing time taken to complete the administration can be longer. It is important that the nurse plans the intravenous medication administration not only to meet the prescription requirements but also to allow time without disruption or pressure to hasten the administration. Assessment for signs of phlebitis, extravasation, infection and pain before, during and after intravenous administration is vital to ensure the patency and viability of the vein. All usual considerations around safe medication administration apply and additional efforts to prevent infection through the application of ANTT in the preparation and administration of the medication are required. Guidelines on correct dilution and administration practices specific to each medication must also be confirmed with either the Australian Injectable Drugs Handbook (AIDH) or the product information leaflet before preparation and administration. Sarina Fazio, PhD, RN, Emma Blackmon, PhD, RN, Amy Doroy, PhD, RN, Ai Nhat Vu and Paul MacDowell, PharmD. | May 26, 2021 Disclosure of Relevant Financial Relationships: As a provider accredited by the Accreditation Council for Continuing Medical Education (ACCME), the University of California, Davis, Health must ensure balance, independence and objectivity in all its CME activities to promote improvements in health care and not proprietary interests of a commercial interest. Authors, reviewers and others in a position to control the content of this activity are required to disclose relevant financial relationships with commercial interests related to the subject matter of this educational activity. The Accreditation Council for Continuing Medical Education (ACCME) defines a commercial interest as “any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on patients” and relevant financial relationships as “financial relationships in any amount occurring within the past 12 months that create a conflict of interest. Patrick Romano, MD, MPH; Debra Bakerjian, PhD, APRN, RN; Sarina Fazio, PhD, RN; Emma Blackmon, PhD, RN, CCRM; Amy L. Doroy, PhD, RN, NEA-BC; Ai Nhat Vu; Paul MacDowell, PharmD, BCPS; Ulfat Shaikh, MD; Patricia Poole, PharmD for this Spotlight Case and Commentary have disclosed no relevant financial relationships with commercial interests related to this CME activity. Learning Objectives
The CaseA 64-year-old woman with a history of anxiety, depression, hypothyroidism, arthritis, paroxysmal atrial fibrillation, an ascending aortic aneurysm, and a bicuspid aortic valve, presented to clinic with several months of worsening dyspnea on exertion. An echocardiogram showed moderate-to-severe aortic stenosis. She then underwent surgery for an aortic valve replacement, ligation of her left atrial appendage, and repair of her ascending aortic aneurysm. Following surgery, the patient experienced intermittent episodes of hypotension, for which she was given intravenous (IV) fluid boluses and vasopressor support. She received IV norepinephrine at a rate of 0.5 - 6 mcg/minute until 21:00 on postoperative day 1. At 08:00 on postoperative day 2, the patient’s blood pressure was 98/59 mmHg and a 250 mL fluid bolus was ordered. The fluid bag was attached to the IV line that had the vasopressor at a Y-site and the bolus was initiated. The patient developed diaphoresis, tachycardia to 114 bpm, and hypertension with an apex value of 271/161 mmHg. Once the inadvertent bolus was recognized, the vasopressor infusion was immediately stopped. In total, the patient received approximately 4.5 mL (or 160 micrograms) of norepinephrine infused over 15 minutes. The patient was then closely monitored, and her hemodynamic parameters returned to baseline approximately 15 minutes later. However, the patient had ongoing hypotension in the hours following the inadvertent bolus of norepinephrine with a nadir of 54/38 mmHg, again requiring vasopressor administration and additional fluid boluses. The next day, the patient's blood pressure stabilized, and she was transferred to a stepdown unit, and later discharged home. While the incident caused only temporary and minor harm to the patient, it was a cause of significant stress and anxiety throughout the rest of her hospital stay and persisted after her discharge. Under different circumstances, this error could have resulted in significant harm, including neurologic impairment and death. The CommentaryBy Sarina Fazio, PhD, RN, Emma Blackmon, PhD, RN, Amy Doroy, PhD, RN, Ai Nhat Vu & Paul MacDowell, PharmD ICU Hypotension Hypotension following cardiac surgery may result from a variety of factors, such as hypovolemia, pump failure due to heart failure or shock, or maldistribution of blood flow due to septic shock.1-3 Severe, systemic vasodilation can occur in 5-25 % of patients following cardiac surgery, resulting in postoperative hypotension despite a normal or increased cardiac index.2,4 Most patients with vasodilatory shock respond to hemodynamic-guided IV fluid therapy and/or low-dose vasopressor agents, such as norepinephrine or vasopressin.3,5,6 Expected mean arterial pressure (MAP) values in the postoperative period are between 60-90 mmHg. Vasopressors are indicated for a MAP < 60 mmHg, a decrease in systolic blood pressure > 30 mmHg from baseline, or when there is risk of end-organ dysfunction due to hypotension.7,8 Prior to initiation of vasopressor therapy, patients should be assessed for hypovolemia which should be corrected with intravascular volume resuscitation,9 as vasopressors may be only partially effective in the setting of coexistent hypovolemia.10 However, for patients with pulmonary edema due to heart failure or acute respiratory distress syndrome, fluids may be cautiously withheld and/or administered in smaller quantities to assess for fluid responsiveness and prevent fluid overload.11,12 Vasopressor Administration & Monitoring Vasopressors are drugs that induce vasoconstriction and elevate MAP.7 They are most safely administered intravenously through a central venous catheter to prevent risk of peripheral extravasation and to facilitate rapid, systemic distribution.13 Despite their life-sustaining benefit, vasopressors and inotropic agents have the potential, at high doses and with prolonged use, to cause serious complications, such as cardiac arrhythmias, myocardial ischemia, peripheral vascular insufficiency and peripheral ischemia.14 Vasopressor administration requires admission to an ICU and continuous cardiac and blood pressure monitoring by an interprofessional team. Infusions are typically titrated by ICU nurses based on provider orders regarding clinical endpoints and hemodynamic goals, such as blood pressure (MAP) and end-organ perfusion, that may differ based on clinical condition.15,16 Figure 1, adapted from Pinkney and colleagues,17 depicts a multi-lumen central venous catheter connected to multiple IV infusions. Figure 1. Multiple IV Infusion Setup Image adapted and printed with permission from Pinkney et al., 201417 Norepinephrine is the preferred, first-line vasopressor for both the treatment of septic and distributive shock.18 Norepinephrine produces vasoconstriction and increases contractility by stimulating alpha and beta1 adrenergic receptors.7 Norepinephrine has a rapid onset of action, with 5 minutes to peak serum steady-state and mean half-life elimination of 2.4 minutes. Norepinephrine can be administered using weight-based or non-weight-based dosing, the latter of which is calculated and rounded for an 80 kg patient. Though dosing and titration parameters may vary across institutions and clinical pathologies, examples of initial dosing and dose ranges are provided in Table 1.15,16
ICU Medication Errors Associated with IV Infusions IV medication administration is an integral component of treating ICU patients. The complexity of medication administration, which can require up to 200 steps from prescription to administration,19 combined with high patient acuity and treatment complexity, makes ICU medication administration particularly error-prone.20Additional factors such as a high number of infusions, administration of high-alert medications, and rapid bolus infusions further increase the likelihood of an IV medication error taking place and a subsequent adverse drug event.21 The Institute for Safe Medication Practices (ISMP) has reported that “56% of medication errors are associated with IV medications,”22 and medication administration is reported to be the most common step at which errors occur, accounting for approximately 66% of ICU medication errors.23 There is substantial heterogeneity in the most prevalent types of IV medication errors in ICU settings, due to differences in data collection methodologies and practices across hospitals. For instance, a prospective, observational Canadian ICU study pre-dating EHR implementation found that incomplete documentation accounted for 92.7% of the IV medication errors observed, whereas inappropriate Y-site or piggyback infusion errors accounted for 6.7% of IV administration errors.20 In contrast, Fahimi and colleagues23 observed that a majority of IV medication errors were related to bolus administration (43.4%) and incorrect infusion rate (23.0%).24 An international study published in 2011 also found errors in bolus IV medication administration to be common and associated with significantly higher error rates than continuous infusions (77.2% vs 47.7%; p<0.0001).25 While overall error rates vary widely, comparable rates (determined using similar measurement methods) of potentially harmful errors (those rated D or above, indicating the majority of patients require extra monitoring or intervention to prevent harm) lie between 0.4-3.8%.26-29 Rate or IV Line Mix-ups In 2015, the Emergency Care Research Institute (ECRI) rated infusion mix-ups as one of the top 10 health technology hazards.30 In the ICU setting, where patients commonly receive multiple IV infusions, IV line or rate mix-ups are common errors that can be attributed to a number of factors including a variety of medication administration routes, difficulties in visually distinguishing between lines (see Figure 2), and inadequate medication reconciliation handoffs.17,30 In a report by the Pennsylvania Patient Safety Advisory, rate and line mix-ups accounted for 23% (n=205) of reported events,24 and most commonly occur with high-alert medications (92%). While there are many types of IV infusion mix-up errors, these types of errors commonly result in medication dosing errors and incorrect amounts of fluid volume delivered to the patient.17 Figure 2. Multiple IV Infusion Administration Image adapted and printed with permission from Pinkney et al., 201417 Errors Associated with Secondary Infusions Secondary (“piggyback”) infusions are IV infusions that are attached to the primary continuous IV infusion and hung above the primary infusion bag to deliver intermittent, scheduled medications, such as antibiotics and electrolytes. Medication errors associated with secondary infusions arise from their complex setup process and include but are not limited to wrong Y-site connection, failure to open the catheter clamp, inappropriate height differential between the primary and secondary infusion bags, and programming errors.24 Secondary infusion errors accounted for approximately 39% of multiple IV infusion incidents reported to the U.S. Food and Administration (FDA) in 2008, 45% of which resulted in patient harm.31 Errors Associated with Norepinephrine The ISMP includes adrenergic agonists (e.g., norepinephrine) among medications that have a heightened risk of causing significant patient harm if used in error.32 Although vasoactive drugs are a class of therapeutic drugs among those most commonly associated with medication errors in adult ICUs and are administered in ICUs globally,33 errors related to vasopressor administration through continuous infusions are infrequently discussed in the literature. The earliest report the authors of this commentary could find of an inadvertent over-infusion of norepinephrine related to a pump programming error that resulted in cardiac arrest and the patient’s subsequent death was published in 2015.34 Given the complexities of dosing and titration when administering norepinephrine, additional research is necessary to identify and examine the effects of risk reduction strategies on patient outcomes. Best Practices in Management of Multiple IV Infusions Over the past 10 years, the potential risks associated with administration of multiple IV infusions in the ICU setting have been increasingly recognized. In 2010, the Association for the Advancement of Medical Instrumentation and the U.S. FDA issued a call to action to improve the management of multiple IV infusions.31,52 Here, we briefly outline some recent leading efforts and system-level approaches to improving vasopressor and multiple IV infusion safety. Utilization of Smart Pumps The use of smart pumps with ‘dose error reduction software’ is becoming more prevalent as a method to reduce the risk of errors associated with IV infusions and pump programming.35 In addition to comprising a drug library, smart pump software of this type is programmed with individual medication parameters, such as acceptable prescribed rate, concentration, and dosing limits.34 While use of smart pumps has the potential to mitigate errors associated with incorrect programming of IV infusions, current smart pumps do not target risks associated with setting up and co-administration of multiple IV infusions.17,24,27 In this regard however, the medication error that occurred in the case that is the focus of this commentary was related to the physical maintenance of the patient’s IV infusions, an underappreciated area of concern that lacks a technological, smart pump prevention solution. Standardized Dosing Though norepinephrine is always administered through an infusion pump, there are additional institutional steps that can be taken for norepinephrine administration that may increase safety. We previously discussed (see section on Vasopressor Administration & Monitoring above) how norepinephrine can be administered using either a weight (mcg/kg/min) or non-weight-based (mcg/min) strategy. Variations in how ICU nurses manage vasoactive medications and identification of practice variations which contribute to medication errors, patient harm and nurse anxiety were the focus of a recent systematic review.36 As reported in the review, ICU nurses aligned their choices of dosing units with the preferences of the patients’ primary medical team; surgical teams are known to favor weight‐based doses while medical teams prefer non‐weight‐based units.37 Conversion to a single method of dosing (e.g., weight-based dosing) can be implemented to prevent errors associated with medication administration. In addition, standardizing vasopressor infusion concentration across care areas and provider services may also prevent norepinephrine IV errors. Standard concentrations of norepinephrine infusions are either 16 mcg/mL (4 mg in 250 mL) or 32 mcg/mL (8 mg in 250 mL) of 5% dextrose in water or normal saline.38 However, if an order to change norepinephrine concentration occurs during medication administration, implementing effective communication or an alerting system is an important additional step to take to ensure smart pump programming updates are reflected and medication/tubing is exchanged properly. For all of these reasons, implementing a standardized dosing strategy has the potential to reduce the risk of medication errors by standardizing preparation and programming of vasoactive infusions.36,37,39-41 IV Infusion Setup Setting up multiple, continuous IV infusions is a common nursing task when caring for a critically ill patient in the ICU. Each additional IV infusion can increase the likelihood of an error occurring by 3% due to increasing demands associated with a) physically managing multiple infusions with limited access points and b) cognitively managing multiple medication orders and titration parameters.21 Research has shown that setting up multiple infusions in parallel, when either initiating IV therapy or changing medications and their tubing, has led to errors related to IV tubing, pumps, drug orders and mixed up labels.42-44 Instead, to decrease the chance of error when setting up multiple IV infusions, it is recommended that each IV infusion be set up one at a time and as completely as possible before moving on to the next infusion.42-45 Furthermore, clinicians should “trace” infusions from top to bottom, or from the administration bag, through the pump, and to the patient, before making any new connections or disconnections, when adjusting any existing medication rates, and during communication handoffs. Line Labeling Several technological solutions have been proposed to improve accurate identification of IV infusions when multiple infusions are being administered. These solutions include color-coded tubing, pre-printed or handwritten adhesive labels, infusion organizers, pump displays, and light-linking systems.17 While additional research will be required to determine which of these solutions results in the fewest errors, the findings from a high-fidelity critical care simulation study suggest that line labels/organizers increase infusion identification accuracy and efficiency.46 However, this solution would require standardization in labelling practices to decrease troublesome variation. For example, ISMP supports 1) use of black and white medication labels (with the exception of the emergency medication or “stat” line label) to promote careful reading to differentiate between infusions47,48 and 2) placement of labels in two standard locations, below the smart pump and near the distal end of the tubing49,50 (see Figure 3). Lastly, line labeling should not be the sole means used to identify medication infusions; the labels should support clinicians in facilitating line tracing.24 Figure 3. Labeling Multiple IV Infusions
Image adapted and printed with permission from Pinkney et al., 201417 Management of Continuous Primary Infusions
Titratable, Intermittent, Low-Dose Infusions: During titration for reduction of vasopressors such as norepinephrine, patients can have periods of time when they are receiving very low and intermittent doses, until their MAP is consistently > 60 mmHg. In these cases, the nurse may decide to keep the IV infusion attached to the central venous catheter to reduce the risk of central-line-associated blood stream infection (CLABSI). In contrast, for patients with labile blood pressure, when vasopressors are being titrated on and off according to medication titration orders, the nurse may disconnect the IV tubing from the patient's central venous catheter port but leave the bag/tubing present and hanging in the room in case the patient requires restarting the vasopressor due to a subsequent drop in blood pressure. However, once the medication order is discontinued, removing intravenous bags and tubing from the patient comprises current best practices. Lastly, vasopressor titration is another high-profile patient safety topic; however, discussion of the intricacies of vasopressor titration is outside the scope of this commentary. Important Considerations Several recommendations for co-administration of multiple IV infusions are outlined in this commentary. However, there are many additional considerations clinicians must account for in “real-world” settings given the nature and complexity of caring for critically ill patients in the ICU setting. Some of the considerations that have not been examined herein include:
ConclusionWhile administration of multiple IV infusions is ubiquitous in the ICU, and there are several established safety parameters associated with medication concentration, dosing and pump programming, the physical dexterity required for administering multiple IV infusions concurrently is underappreciated and lack thereof can, in fact, lead to serious harm. More research into this patient safety issue should be conducted. Also, standard guidelines detailing safe practices for administration of multiple IV infusions would benefit both patients and clinicians and should, therefore, be generated. Furthermore, clinicians should be supported with targeted education, establishment of best practices, and bedside clinical decision tools to help them mitigate errors associated with administration of multiple, high-alert IV infusions in the ICU. Take-Home Points
Sarina A. Fazio, PhD, RN Emma J. Blackmon, PhD, RN, CCRN Amy L. Doroy, PhD, RN, NEA-BC, RN-BC Ai Nhat Vu Paul MacDowell, PharmD, BCPS References
How do you administer IV bolus?Administer the medication: (1) Clean the injection port with an antiseptic swab. Release the clamp. (2) Insert a syringe containing normal saline 0.9% through the injection port of the IV lock. (3) Pull back gently on the plunger of the syringe, and check for blood return.
How does bolus assist with IV medication administration?An IV “push” or “bolus” is a rapid injection of medication. A syringe is inserted into your catheter to quickly send a one-time dose of a drug into your bloodstream.
Which nursing intervention is most important in ensuring safe infusion of a medication delivered by IV piggyback through a saline lock?Which nursing intervention is most important in ensuring safe infusion of a medication delivered by IV piggyback through a saline lock? Use the most proximal insertion port on the primary tubing.
Which nursing intervention is implemented to prevent accidental needlestick injuries?Some interventions that have been critical for reducing sharp injuries include avoiding recapping needles when possible or using one-handed recapping when appropriate. Also, wearing gloves or double-gloving effectively reduces the incidence of percutaneous injuries in the healthcare setting.
|